Result of Retail Offer

Further to the announcement dated 21 December 2023, GENinCode plc (AIM: GENI), the polygenics company focused on the prevention of cardiovascular disease ("CVD"), is pleased to announce that, following the closing of the Retail Offer on the BookBuild platform on 27 December 2023, 1,147,560 Ordinary Shares will be issued at the Issue Price of 5 pence per Retail Offer Share in connection with the Retail Offer, raising an additional £57,378.

Consequently, conditional on the passing of the Resolutions at the General Meeting, 67,576,000 Placing Shares, 12,424,000 Subscription Shares and 1,147,560 Retail Offer Shares, resulting in a total of 81,147,560 new Ordinary Shares, will be issued in relation to the Placing, Subscription and Retail Offer, raising total gross proceeds of £4.06 million.

Admission and Total Voting Rights

Application has been made for the Retail Offer Shares to be admitted to trading on AIM ("Admission"). Admission is expected to take place at 8.00 a.m. on or around 10 January 2024.

Following Admission, the total number of Ordinary Shares in the capital of the Company in issue will be 176,964,426 with each Ordinary Share carrying the right to one vote. There are no shares held in treasury and therefore, following Admission, the total number of voting rights in the Company will be 176,964,426. The above figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure, Guidance and Transparency Rules.

Capitalised terms used in this announcement have the meaning given to them in the Placing and Retail Offer announcement dated 21 December 2023, unless otherwise defined in this announcement.